ENLV Enlivex Ltd.
Finance Services · Nasdaq · SEC CIK 1596812 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY—
TTM net income YoY8,329.2%
TTM EPS YoY3,590.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE126.2%
ROA104.9%
ROIC (approx.)-1.2%
Asset turnover—
Leverage & solvency
Liabilities / assets16.8%
Debt / equity0.00x
Current ratio193.24x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.01x
Accruals ratio105.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | — | — | — |
| R&D expense | $9.20M | $10.62M | $19.01M | $18.69M | $12.88M |
| SG&A expense | $5.80M | $4.91M | $6.14M | $7.10M | $6.41M |
| Operating income | -$15.03M | -$15.89M | -$29.39M | -$25.80M | -$19.29M |
| Pretax income | $1.62B | -$15.01M | -$29.07M | — | $14.47M |
| Income tax | $382.65M | — | — | — | — |
| Net income | $1.24B | -$15.01M | -$29.07M | -$31.06M | -$14.47M |
| EBITDA | -$14.70M | -$15.34M | -$28.56M | -$25.02M | -$18.74M |
| EPS (basic) | 27.04 | -0.73 | -1.56 | -1.69 | -0.81 |
| EPS (diluted) | 25.48 | -0.73 | -1.56 | -1.69 | -0.81 |
| Weighted avg. shares (diluted) | 48.50M | 20.51M | 18.57M | 18.39M | 17.86M |
| Banking | |||||
| Deposits | — | — | — | $47.82M | $10.00M |
| Balance sheet | |||||
| Cash & equivalents | $1.89M | $3.30M | $1.23M | $50.36M | $11.64M |
| Short-term investments | — | $198,000 | $5.11M | $299,000 | $62.92M |
| Current assets | $1.74B | $25.99M | $33.76M | $52.33M | $86.44M |
| PP&E, net | $361,000 | $625,000 | $1.54M | $9.88M | $2.53M |
| Total assets | $2.33B | $27.69M | $36.83M | $67.64M | $95.15M |
| Current liabilities | $9.02M | $3.80M | $6.06M | $6.61M | $4.72M |
| Short-term debt | — | — | — | $299,000 | $10.00M |
| Total liabilities | $392.05M | $4.10M | $6.75M | $10.80M | $10.11M |
| Shareholders' equity | $1.93B | $23.59M | $30.08M | $56.84M | $85.04M |
| Shares outstanding | 237.38M | 23.65M | 18.60M | 18.42M | 18.33M |
| Cash flow statement | |||||
| Operating cash flow | -$10.42M | -$13.01M | -$23.52M | -$23.95M | -$17.54M |
| Capital expenditure | $68,000 | $103,000 | $236,000 | $8.12M | $1.62M |
| Free cash flow | -$10.48M | -$13.11M | -$23.76M | -$32.08M | -$19.17M |
| Investing cash flow | -$1.32M | $9.06M | -$25.97M | $62.52M | -$38.41M |
| Financing cash flow | $10.38M | $6.45M | $360,000 | $150,000 | $60.98M |
| Depreciation & amortization | $332,000 | $545,000 | $835,000 | $777,000 | $546,000 |
| Stock-based compensation | $1.78M | $2.06M | $1.95M | $2.71M | $2.91M |
Free plan shows the latest 5 periods; Pro shows all 14 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.